CIK 0001783183
- Non-accelerated filer
- Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 824151574
- Phone
- +1 877-742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-27 | Curran Terrie President and Chief Executive | Grant or award · Stock Option (Right to Buy) | +342,500 | 342,500 | ||
| 2025-01-21 | Curran Terrie President and Chief Executive | Sale | −19,109 | $6.59 | $126K | 360,465 |
| 2024-07-15 | Curran Terrie President and Chief Executive | Sale | −33,848 | $11.72 | $397K | 377,734 |
| 2024-03-22 | Curran Terrie President and Chief Executive | Sale | −16,851 | $9.11 | $154K | 410,784 |
| 2024-01-18 | Curran Terrie President and Chief Executive | Grant or award · Stock Option (Right to Buy) | +475,000 | 475,000 | ||
| 2023-11-01 | Curran Terrie President and Chief Executive | Grant or award | +37,500 | 427,171 | ||
| 2023-07-14 | Curran Terrie President and Chief Executive | Grant or award | +200,000 | 389,671 | ||
| 2023-07-14 | Curran Terrie President and Chief Executive | Returned to the company · Stock Option | −175,000 | 0 | ||
| 2023-07-14 | Curran Terrie President and Chief Executive | Returned to the company · Stock Option | −225,000 | 0 | ||
| 2023-04-06 | Curran Terrie President and Chief Executive | Purchase | +12,919 | $7.82 | $101K | 188,290 |
| 2023-03-01 | Curran Terrie President and Chief Executive | Sale | −1,436 | $8.54 | $12K | 175,371 |
| 2023-01-20 | Curran Terrie President and Chief Executive | Sale | −5,821 | $8.20 | $48K | 176,807 |
| 2023-01-19 | Curran Terrie President and Chief Executive | Grant or award | +97,500 | 182,628 | ||
| 2023-01-19 | Curran Terrie President and Chief Executive | Grant or award · Stock Option (Right to Buy) | +162,500 | 162,500 | ||
| 2022-11-21 | Curran Terrie President and Chief Executive | Sale | −1,526 | $9.60 | $15K | 83,720 |
| 2022-09-01 | Curran Terrie President and Chief Executive | Grant or award | +7,500 | 85,246 | ||
| 2022-05-19 | Curran Terrie President and Chief Executive | Grant or award | +12,000 | 76,595 | ||
| 2022-05-13 | Curran Terrie President and Chief Executive | Purchase | +20,500 | $7.41 | $152K | 64,595 |
| 2022-01-19 | Curran Terrie President and Chief Executive | Grant or award | +41,250 | 44,095 | ||
| 2022-01-19 | Curran Terrie President and Chief Executive | Grant or award · Stock Option (Right to Buy) | +206,250 | 206,250 |
Page 1 of 2 · 26 trades